HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): John R. Liddicoat Frank L. Hanley Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reddy, V. M. Articles by Hanley, F. L. Search for Related Content PubMed PubMed Citation Articles by Reddy, V. M. Articles by Hanley, F. L.

J Thorac Cardiovasc Surg 1996;111:536-544
© 1996 Mosby, Inc.

SURGERY FOR CONGENITAL HEART DISEASE

LONG-TERM FETAL OUTCOME AFTER FETAL CARDIAC BYPASS: FETAL SURVIVAL TO FULL TERM AND ORGAN ABNORMALITIES

From the Division of Cardiothoracic Surgery, University of California San Francisco, San Francisco, Calif.

Address for reprints: Frank L. Hanley, MD, 505 Parnassus Ave., M593, San Francisco, CA 94143-0118

Abstract

Background: Earlier work suggests that fetal cardiac bypass is technically feasible but results in significant placental dysfunction. Many of the stimuli that initiate this placental dysfunction have been identified in the past several years and these involve fetal stress, extracorporeal surfaces, priming substances (maternal blood), and flow characteristics. Fetal survival with conventional methods of bypass has been far less than optimal. A novel fetal bypass circuit requiring no priming volume was designed incorporating an in-line axial flow pump (Hemopump, Johnson & Johnson Interventional Systems, Rancho Cordova, Calif.) and was demonstrated to have a marked beneficial effect on placental function.

Objective: The purpose of this study was to investigate the effect of this newly developed customized fetal bypass circuit on fetal survival and developing fetal organs.

Methods and results: Nine fetuses at 122 to 126 days of gestation were subjected to fetal cardiac bypass via a transsternal approach, with a 16F single right atrial venous cannula and a 12F arterial cannula. Normothermic cardiac bypass was continued for 30 minutes at flow rates of 320 ± 32 ml/kg. Of the nine fetuses, one fetus was stillborn 4 days after bypass and eight (89%) were delivered alive after progressing to term gestation. One lamb died of blunt trauma 1 day after birth. All other lambs (n = 7) thrived normally, and at 1 week of age they were subjected to autopsy. No gross hemorrhagic or thromboembolic lesions were detected in the organs examined including the brain. Microscopic examination of representative sections from all organs revealed mild pleural reaction in two lambs, and in two other lambs the hepatocytes showed evidence of mild increase in glycogen content, the significance of which is unknown in relation to fetal bypass. In one fetus that was aborted there was evidence of mild to moderate neuronal loss in the cerebral cortex.

Conclusion: This study demonstrates that with improvements in fetal extracorporeal circuitry and techniques very favorable fetal outcome can be achieved. Further studies are necessary to evaluate the effects of bypass on fetal brain in an appropriate animal model. Advances in extracorporeal circuitry to suit the unique fetal physiology increase the possibility of future clinical application. (J THORACCARDIOVASCSURG1996;111:536-44)

This article has been cited by other articles:

				J. Lombardi, J. Sedgwick, J. Schenbeck, W. Lubbers, R. E Ferguson, A. Gardner, J. L McNamara, and P. Eghtesady Cardiopulmonary bypass in the immature fetus through novel use of a mini-centrifugal pump Perfusion, May 1, 2006; 21(3): 185 - 191. [Abstract] [PDF]

				A. Ikai, R. K. Riemer, C. Ramamoorthy, S. Malhatra, L. Cassorla, G. Amir, F. L. Hanley, and V. M. Reddy Preliminary results of fetal cardiac bypass in nonhuman primates J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 175 - 181. [Abstract] [Full Text] [PDF]

				Y. Oishi, M. Masuda, T. Yasutsune, N. Boku, S. Tokunaga, S. Morita, and H. Yasui Impaired Endothelial Function of the Umbilical Artery After Fetal Cardiac Bypass Ann. Thorac. Surg., December 1, 2004; 78(6): 1999 - 2003. [Abstract] [Full Text] [PDF]

				A. Carotti, F. Emma, S. Picca, E. Iannace, S. B. Albanese, M. Grigioni, F. Meo, M. Sciarra, and R. M. Di Donato Inflammatory response to cardiac bypass in ewe fetuses: effects of steroid administration or continuous hemodiafiltration J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1839 - 1848. [Abstract] [Full Text] [PDF]

				A. J. Parry, E. Petrossian, D. B. McElhinney, V. M. Reddy, and F. L. Hanley Neutrophil degranulation and complement activation during fetal cardiac bypass Ann. Thorac. Surg., August 1, 2000; 70(2): 582 - 589. [Abstract] [Full Text] [PDF]

				A. F. Rossi, H. S. Seiden, A. M. Sadeghi, K. H. Nguyen, C. S. Quintana, R. P. Gross, and R. B. Griepp The outcome of cardiac operations in infants weighing two kilograms or less J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 28 - 32. [Abstract] [Full Text]

				R. S. Assad and F. L. Hanley Editorial: Artificial placenta--a need for fetal surgery? J. Thorac. Cardiovasc. Surg., May 1, 1998; 115(5): 1021 - 1025. [Full Text] [PDF]

				M. Sakata, K. Hisano, M. Okada, and M. Yasufuku A New Artificial Placenta with a Centrifugal Pump: Long-Term Total Extrauterine Support of Goat Fetuses J. Thorac. Cardiovasc. Surg., May 1, 1998; 115(5): 1023 - 1027. [Abstract] [Full Text] [PDF]

				J. J Sistino Foetal bypass: concepts and controversies Perfusion, March 1, 1998; 13(2): 111 - 117. [Abstract] [PDF]